Notably, the CD27/CD70 signaling pathway has been extensively linked to the promotion of autoimmune diseases, whereas CD52 has been associated with inflammation suppression, suggesting that DCs may exert a dual mode of action on T cells (23, 24). Here, CD52 is linked to autoimmune disease.